[ad_1] Nasdaq-listed mainland China anti-cancer drug research and development company, Baiji Shenzhou (06160), will raise funds for the future, raising up to $ 7.32 billion yuan, whose entry is scheduled for August …
Read More »[ad_1] Nasdaq-listed mainland China anti-cancer drug research and development company, Baiji Shenzhou (06160), will raise funds for the future, raising up to $ 7.32 billion yuan, whose entry is scheduled for August …
Read More »